Search

Your search keyword '"Ayrignac, Xavier"' showing total 597 results

Search Constraints

Start Over You searched for: Author "Ayrignac, Xavier" Remove constraint Author: "Ayrignac, Xavier"
597 results on '"Ayrignac, Xavier"'

Search Results

4. PFMG2025–integrating genomic medicine into the national healthcare system in France

5. MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS

6. Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases

7. A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica

8. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.

11. Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia.

13. Primary brain calcification: an international study reporting novel variants and associated phenotypes.

14. High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families

15. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study

19. Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases

24. MRI features of demyelinating disease associated with anti-MOG antibodies in adults

25. Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations

26. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

28. Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGADin Adults: The MOGADOR2 Study.

29. Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study.

31. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions

32. CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis

33. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

34. Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

35. Description of neurotoxicity in a series of patients treated with CAR T-cell therapy

36. Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

37. Two neurologic facets of CTLA4-related haploinsufficiency

38. Brain MRI features and scoring of leukodystrophy in adult-onset Krabbe disease

39. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers

40. Diffusion-weighted magnetic resonance imaging in early central retinal artery occlusion

44. Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion

47. MRI volumetric morphometry in vascular parkinsonism

48. The radiologically isolated syndrome: revised diagnostic criteria

50. Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients

Catalog

Books, media, physical & digital resources